v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net loss $ (13,404,539) $ (3,785,769)
Less: net loss - discontinued operations (3,050) (174,054)
Net loss - continuing operations (13,401,489) (3,611,715)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 2,174,582 3,970
Amortization of right-of-use asset 243,951
Loss on debt extinguishment 113,955
Derivative expense 1,486,387 611,583
Change in fair value of derivative liabilities (2,028,810)
Amortization of debt discount 2,031,240 186,318
Bad debt expense 58,769
Stock issued for services 366,720 48,801
Stock issued for intellectual property 253,400
Stock issued for financing costs 995
Vesting of Series C - preferred stock - issued as compensation 1,810,840 1,077,800
Interest expense incurred in connection with increase in debt principal 48,805 73,750
Increase (decrease) in    
Accounts receivable (188,366) (50,809)
Inventory (18,668) (187)
Prepaids and other (13,790) 57,470
Accounts payable and accrued expenses (221,571) 1,445,898
Accounts payable and accrued expenses - related party 2,271,092 (613,476)
Deferred revenues 4,071
Operating lease liability (3,176)
Net cash used in operating activities - continuing operations (5,126,013) (655,647)
Net cash used in operating activities - discontinued operations (89,964) (9,607)
Net cash used in operating activities (5,215,977) (665,254)
Investing activities    
Cash acquired in acquisitions 1,269,000 28,253
Acquisition of property and equipment (252,179) (39,700)
Acquisition costs secured by debt (283,343)
Net cash provided by (used in) investing activities 1,016,821 (294,790)
Financing activities    
Proceeds from common stock issued for cash 894,423
Repayments on notes payable (18,272)
Proceeds from convertible notes payable 3,903,248 959,650
Repayments on mortgage notes payable (197,783)
Net cash provided by (used in) financing activities 4,581,616 959,650
Net increase (decrease) in cash 382,460 (394)
Cash - beginning of period 350,231 148,294
Cash - end of period 732,691 147,900
Supplemental disclosure of cash flow information    
Cash paid for interest 1,674,399
Cash paid for income tax
Supplemental disclosure of non-cash investing and financing activities    
Issuance of Series C - convertible preferred stock in connection with acquisition of Rancho Mirage 42,280,080
Issuance of Series C - convertible preferred stock in connection with acquisition of Victorville 39,000,060
Contingent consideration arrangement - Series C - convertible preferred stock - Victorville 7,125,000
Contingent consideration arrangement - Series C - convertible preferred stock - Rancho Mirage 4,800,000
Forgiveness of pre-existing relationship with target acquiree 2,652,671
Net deficit of Victorville and Rancho Mirage acquisitions 2,617,000
Discounts in connection with issuance of debt and warrants - convertible notes payable 4,596,471 855,076
Right-of-use asset obtained in exchange for new operating lease liability 2,091,012
Common stock issued in connection with conversion of convertible notes payable 1,200,107
Warrants issued as deferred offering costs 258,723
Cashless exercise of warrants 2,466
Conversion of accounts payable into convertible note payable - related party 73,927
Issuance of Series C - convertible preferred stock in connection with acquisition of SWC 4,399,982
Issuance of Series C - convertible preferred stock in connection with acquisition of Skytech 528,000
Deemed dividend associated with Series B, convertible preferred stock - dilutive warrant adjustments 11,566
Common stock issued in connection with conversion of preferred stock 83
Net equity of SWC acquired 2,575,187
Net equity of Skytech acquired $ 262,150